top of page
MedMira
Apr 30, 20242 min read
MedMira Announces the Hire of Vice President of Business Development
Halifax, Nova Scotia,30 April, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to announce the expansion of their...
MedMira
Apr 19, 20241 min read
Innovation made easy
With MedMira's patented RVF Technology, there are a myriad of possibilities: As an example, our latest custom made product for one of our...
MedMira
Mar 13, 20244 min read
MedMira Receives Canadian Patent for its Unique Quantitative Diagnostic System
Halifax, Nova Scotia, March 13, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the receipt of a Canadian patent...
MedMira
Feb 1, 20243 min read
Corporate Update on Clinical Evaluation of MedMira’s Products
Halifax, Nova Scotia,1 February, 2024 – Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review...
MedMira
Dec 13, 20233 min read
U.S. FDA Approves MedMira’s Advanced Reveal® G4 Rapid HIV-1/2 Antibody Test
Halifax, Nova Scotia, 13 December, 2023 – Today, MedMira Inc. (MedMira) (TSXV: MIR) MedMira Inc. proudly announces today the successful...
MedMira
Nov 28, 20232 min read
FY2023 Update
Corporate Update Throughout the reporting period, the Company achieved significant milestones in its pursuit of FDA and Health Canada...
bottom of page